This live Symposium is approved for 8.75 AMA PRA Category 1 Credit(s) TM and 8.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Cerficaon (MOC) program, 8.5 CNE contact hours, and 8.5 CPE contact hours by the Purdue University College of Pharmacy. 17 th Annual Indy Hematology Review Organized by: Indy Hematology Educaon, Inc. Presented by: Saturday, March 21, 2020 The Wesn Indianapolis 241 W. Washington St. Indianapolis, IN 46204 A full day of presentaons by today’s leaders in Hematology and Hematologic Malignancies Achieving tomorrow’s outcomes through education today.
8
Embed
Indy Hematology Review Registration Brochure...The Indy Hematology Review brings together over 400 hematologists, oncologists, radiologists, physician assistants, oncology RN’s,
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
This live Symposium is approved for 8.75 AMA PRA Category 1 Credit(s)TM and 8.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM)
Maintenance of Certification (MOC) program, 8.5 CNE contact hours, and 8.5 CPE contact hours by the Purdue University College of Pharmacy.
17th AnnualIndy Hematology Review
Organized by: Indy Hematology Education, Inc.
Presented by:
Saturday, March 21, 2020The Westin Indianapolis 241 W. Washington St.Indianapolis, IN 46204
A full day of presentations by today’s leaders in Hematology and Hematologic Malignancies
Achieving tomorrow’s outcomes through education today.
Register online: www.indyhematologyreview.com
Participating in the Symposium will affect competence, performance and patient outcomes in a variety of ways:1. �Attendees�will�be�able�to�implement�the�most�clinically�effective�management�strategies�for�the�
Visit the Exhibit HallVisit�the�exhibit�hall�to�experience�the�latest�technology,�services,�devices�and�research�in�hematology.�The�exhibit�hall�offers�an�opportunity�to�learn�about�a�wide�range�of�products�and�services�offered�by�pharmaceutical�companies,�medical�suppliers,�biotechnology�companies,�healthcare�systems,�and�research-based�companies.�Stop�in�for�a�beverage�and�snack�at�the�“Physicians’�Lounge”�as�you�visit�exhibitors.
The 2020 Indy Hematology Review is supported by: Agios
Alexion PharmaceuticalsAmgen
AstraZenecaBeiGene Ltd
Bristol-Myers SquibbBTG International, Inc
Clovis OncologyCoherus BioSciences
ImmunomedicsIncyte CorporationJanssen Oncology
Jazz PharmaceuticalsNovo Nordisk, Inc
Pfizer, Inc.Rigel Pharmaceuticals
Seattle GeneticsSanofi Genzyme
Stemline Therapeutics
BOARD OF DIRECTORSRuemu�E.�Birhiray,�MD,�President�and�CEO�
Michael�C.�Wiemann,�MD,�FACP,�Vice-President
Donna�M.�Birhiray,�OT,�MBA,�Treasurer
Jennifer�Terry,�JD,�Secretary
Thalia�Hammond,�Director
Indiana Community Cancer Care Foundation, IncAmerican Oncology Network
Register online: www.indyhematologyreview.com
7:00 AM – 2:30 PM – Registration
7:00 AM – 4:45 PM – Exhibit displays
7:30 AM – Breakfast Product Theaters
8:30 AM – State of the Art: 2020 Emerging Therapies in Hematologic MalignanciesRuemu�E.�Birhiray,�MD�–�ChairCEO,�Indy�Hematology�Education,�Inc.Associate�Professor�of�Clinical�Medicine,�Marian�University�of�Osteopathic�MedicinePartner�and�Vice�President,�Hematology�Oncology�of�Indiana,�PC�(Indianapolis,�IN)
9:00 AM – Emerging Treatment Paradigms in Multiple Myeloma: Targeting the Neighborhood and Beyond Kenneth�Anderson,�MDKraft�Family�Professor�of�Medicine,�Harvard�Medical�SchoolProgram�Director�of�the�Lebow�Institute�for�Myeloma�Therapeutics�and�Jerome�Lipper�Multiple�Myeloma�Center,�Dana-Farber�Cancer�Institute�(Boston,�MA)
9:30 AM – Waldenström’s Macroglobulinemia: Choosing Wisely in Prognostication and Treatment in 2020Steven�Treon,�MD,�MA,�PhD,�FACP,�FRCPAssociate�Professor�of�Medicine,�Harvard�Medical�SchoolSenior�Attending�Physician�for�Medical�Oncology�at�DFCI�and�Brigham�&�Women’s�HospitalDirector�of�the�Bing�Center�for�Waldenström’s�Macroglobulinemia�Dana-Farber�Cancer�Institute�(Boston,�MA)
10:00 AM – Chronic Lymphocytic Leukemia: Who, When and How to Treat in 2020Steven�Coutre,�MDProfessor�of�Medicine�in�Hematology,�Stanford�University�Medical�Center�(Palo�Alto,�CA)
10:30 AM – Break with Q & A
10:45 AM – Who, When and How to Treat: The Paradox of Watching, Treatment and Retreatment in Indolent Lymphomas in 2020Bruce�Cheson,�MD,�FACP,�FAAS,�FASCOProfessor�of�Medicine,�Head�of�Hematology�and�Cellular�TherapyDeputy�Chief,�Hematology-Oncology,�and�Fellowship�Program�Director�at�Medstar�Georgetown�University�Hospital�Lombardi�Comprehensive�Cancer�Center�(Washington,�DC)
11:15 AM – Current Therapy in Aggressive B and T Cell Lymphomas: An UpdateJohn�Leonard,�MDAttending�Physician,�New�York-Presbyterian�HospitalRichard�T.�Silver�Distinguished�Professor�of�Hematology�and�Medical�OncologyAssociate�Dean�of�Clinical�Research�and�Associate�Director�of�the�Cancer�Center�atWeill�Cornell�Medical�College�(New�York,�NY)
11:45 AM – Novel Therapy of Acute Lymphoblastic Leukemia: DRIVERS, CARS and Targeted TherapyHagop�Kantarjian,�MDSamsung�Distinguished�University�Chair�in�Cancer�Medicine,�Associate�Vice�President�for�Global�Academic�Programs,Professor�and�Department�Chair,�Department�of�Leukemia,�Division�of�Cancer�MedicineThe�University�of�Texas�MD�Anderson�Cancer�Center�(Houston,�TX)
12:15 PM – Benign Hematology: Current Treatment of Cytopenias and Coagulopathies Craig�Kessler,�MDProfessor�of�Medicine�and�PathologyDirector�of�Clinical�Coagulation�Laboratory�in�Department�of�Laboratory�MedicineLombardi�Comprehensive�Cancer�CenterMedstar�Georgetown�University�Medical�Center�(Washington,�DC)
12:45 PM – Q & A
1:00 PM – Lunch Product Theaters
2:00 PM – T. HOWARD LEE KEYNOTE LECTURE: State of the Art: Current and Emerging Treatment of Hodgkin’s Lymphoma Julie�Vose,�MD,�MBAThe�Neumann�M.�and�Mildred�E.�Harris�Professor�and�Chief�in�the�Division�of�Oncology/Hematology�at�UNMC.Fred�&�Pamela�Buffett�Cancer�Center�and�Cancer�Center�at�Village�Pointe�Health�Center�(Omaha,�NE)
3:55 PM – A Global Perspective of Current Treatment Strategies of Myeloproliferative NeoplasmsAlessandro�Vannucchi,�MDAssociate�Professor�of�Hematology,�University�of�Florence�(Florence,�Italy)
4:25 PM – Break with Q & A
4:40 PM – Bad Blood: Treatment of Complimentinopathies and Aplastic AnemiaRobert�Brodsky,�MDDirector�of�Division�of�HematologyJohns�Hopkins�Family�Professor�of�Medicine�and�OncologyJohns�Hopkins�University�School�of�Medicine�(Baltimore,�MD)
SYMPOSIUM AGENDA
Register online: www.indyhematologyreview.com
8:30 AM – State of the Art: 2020 Emerging Therapies in Hematologic MalignanciesRuemu�E.�Birhiray,�MD�–�Chair
9:00 AM – Indolent Lymphomas and Hodgkin’s LymphomaBruce�Cheson,�MD,�FACP,�FAAS,�FASCO
9:30 AM – Benign Hematology and CoagulopathyCraig�Kessler,�MD
10:00 AM – Break with Q & A
10:10 AM – Aggressive LymphomasJulie�Vose,�MD,�MBA
10:40 AM – Chronic Leukemias Steven�Coutre,�MD
11:10 AM – Break with Q & A
11:20 AM – Myeloproliferative Neoplasms: Diagnosis, Prognostication and Treatment OptionsAlessandro�Vannucchi,�MD
11:45 AM – Management of Long-Term Survivors of Hematologic MalignanciesKristi�Orbaugh,�RN,�MSN�RNP,�AOCNAdult�Nurse�PractitionerCommunity�Hospital�Oncology�Physicians�(Indianapolis,�IN)
12:10 PM – Managing Drug Interaction with Oral Oncolytics in the Management of Hematologic MalignanciesDavid�Reeves,�PharmD,�BCOPAssociate�Professor�of�Pharmacy�Practice,�College�of�Pharmacy�and�Health�Sciences,�Butler�University�Clinical�Pharmacy�Specialist�in�Hematology/Oncology,�Franciscan�Physician�Network�Oncology/Hematology�Specialist�(Indianapolis,�IN)
12:35 PM – Multiple Myeloma and Waldenström’sMorie�Gertz,�MD
12:55 PM – Break with Q & A
1:00 PM – Lunch: Product Theaters
2:00 PM – Adjourn and join General Session for T. Howard Lee Lecture
NURSING AND ALLIED PROVIDERS SYMPOSIUM AGENDA
Disclosure information, biographies, and slides (where authorized by the presenter) will be available at indyhematologyreview.com
5:40 PM – Myelodysplastic Syndrome: What is New in 2020?Richard�Stone,�MDChief�of�Staff�and�Director�of�Translational�Research,�Adult�Leukemia�ProgramProfessor�of�Medicine,�Harvard�Medical�School�Dana-Farber�Cancer�Institute�(Boston,�MA)
6:10 PM – How I Treat: The Practice of Hematopoietic Stem Cell Transplantation in 2020Richard�Childs,�MD,�RADM,�USPHSClinical�Director,�National�Heart,�Lung,�and�Blood�Institute�(NHLBI)National�Institutes�of�Health�(Bethesda,�MD)
6:40 PM – Break
7:00 PM – Town Hall Reception
7:00 PM – 8:30 PM – Hematologic Malignancies Town HallRuemu�E.�Birhiray,�MD.�ChairMorie�Gertz,�MD,�MACPRoland�Seidler�Jr.�Professor,�Art�of�Medicine,�Chair�Emeritus,�Department�of�Internal�Medicine,�Mayo�Clinic�(Rochester,�MN)Harry�Erba,�MD,�PhD
HOTEL RESERVATIONSMake�reservations�online to reserve a room.�You�may�call�The�Westin�Indianapolis�toll�free�at�1-800-937-8461.Mention�“Indy�Hematology�Review”�for�the�discounted�group�rate�of�$160�plus�tax�(currently�17%).�The�block�of�discounted�rooms�will�close�on�Friday,�March�6,�2020.
DESIGNATION STATEMENTPurdue�University�College�of�Pharmacy�designates�this�live�activity�for�a�maximum�of�8.75 AMA PRA Category 1 Credit(s)™. Symposium�-�8�am�-�6:30�pm.��Purdue�University�College�of�Pharmacy�designates�this�live�activity�for�a�maximum�of�1.50�AMA�PRA�Category�1�Credit�TM�(Town�Hall�Interactive�Meeting�-�7�-�8:30�pm).�Physicians�should�claim�only�the�credit�commensurate�with�the�extent�of�their�participation�in�the�activity.